XML 47 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Information

(16) Segment Information

The Company operates as a single operating segment, which is the business of developing, manufacturing and distributing chemical, biological and biorational products for agricultural, commercial and consumer uses. The Company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection.

The Company’s CODM is the Chief Executive Officer, who manages the Company’s operations based on consolidated financial information for purposes of evaluating financial performance and allocating resources. The financial information reviewed by the CODM includes revenue by product line and region, and key expense categories that are regularly provided for the consolidated company.

The accounting policies of the Company’s single operating segment are the same as those described in the summary of significant accounting policies. Although there are other measures of operating performance used by the CODM, the Company concluded that consolidated operating (loss) income is the measure required to be disclosed as the segment measure of profit or loss. Operating (loss) income is utilized to evaluate to monitor budget versus actual results in order to gain more depth and understanding of the factors driving the business. When evaluating the Company’s financial performance, the following table sets forth significant expense categories regularly provided to the CODM:

 

 

 

2024

 

 

2023

 

 

2022

 

Net sales

 

$

547,306

 

 

$

579,371

 

 

$

609,615

 

Cost of sales:

 

 

 

 

 

 

 

 

 

Material and other costs

 

 

(381,784

)

 

 

(354,580

)

 

 

(368,263

)

Warehousing, handling, and outbound freight

 

 

(45,205

)

 

 

(45,627

)

 

 

(48,964

)

Total cost of sales

 

 

(426,989

)

 

 

(400,207

)

 

 

(417,227

)

Gross profit

 

 

120,317

 

 

 

179,164

 

 

 

192,388

 

Operating expenses

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

(119,634

)

 

 

(116,887

)

 

 

(119,921

)

Research, product development and regulatory

 

 

(32,662

)

 

 

(38,025

)

 

 

(31,816

)

Transformation

 

 

(20,162

)

 

 

(957

)

 

 

—

 

Asset impairment charges

 

 

(50,414

)

 

 

—

 

 

 

—

 

Gain from sale of assets

 

 

1,000

 

 

 

—

 

 

 

—

 

Operating (loss) income

 

 

(101,555

)

 

 

23,295

 

 

 

40,651

 

Change in fair value of equity investments, net

 

 

(2,356

)

 

 

(359

)

 

 

(732

)

Interest and other expenses, net

 

 

(16,547

)

 

 

(12,639

)

 

 

(3,954

)

(Loss) income before provision for income taxes

 

 

(120,458

)

 

 

10,297

 

 

 

35,965

 

Provision for income taxes

 

 

(5,882

)

 

 

(2,778

)

 

 

(8,561

)

Net (loss) income

 

$

(126,340

)

 

$

7,519

 

 

$

27,404

 

 

Assets provided to the CODM are consistent with those reported on the consolidated balance sheet.